MYRG
MYR Group Inc.
MYRG has lower modeled downside risk, despite its lower overall score.
VRT
Vertiv Holdings Co
VRT has the edge over MYRG overall, supported by stronger valuation and stronger fundamentals.
MYRG Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Stable | |
| Healthy |
MYRG's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
VRT Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
VRT's revenue, profitability, cash flow and balance sheet are all currently strong.
MYRG PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 17x | $214 | -23% |
| Forward | 19x | $278 | — |
| Current | 23x | $278 | — |
| Fair | 24x | $300 | +7.6% |
| Expensive | 42x | $513 | +84% |
Historical ranges are pointers, not guarantees.
MYRG's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 19x next year's earnings, in its cheap range.
VRT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 23x | $210 | — |
| Current | 39x | $210 | — |
| Cheap | 58x | $308 | +47% |
| Fair | 72x | $383 | +83% |
| Expensive | 88x | $472 | +125% |
Historical ranges are pointers, not guarantees.
VRT has the edge over MYRG in the historical PE scenario, which offers more potential upside but is not a forecast.
MYRG Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Strong growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect strong earnings and revenue growth for MYRG, with profitability improving. However, they disagree widely on these estimates.
VRT Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| Moderate |
Analysts expect strong earnings and revenue growth for VRT, with profitability improving.
MYRG Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $14.56 | +18% |
| Q3 2026 | $12.31 | +100% |
| Q2 2026 | $10.54 | +121% |
| Q1 2026 | $9.07 | +320% |
| Q4 2025 | $7.53 | +311% |
| Q3 2025 | $6.17 | +172% |
| Q2 2025 | $4.77 | +64% |
| Q1 2025 | $2.16 | -58% |
| Q4 2024 | $1.83 | -66% |
MYRG earned $12.31 per share over the past year, up 100% from the year before.
VRT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.14 | +71% |
| Q3 2026 | $5.35 | +102% |
| Q2 2026 | $4.42 | +111% |
| Q1 2026 | $3.98 | +131% |
| Q4 2025 | $3.41 | +166% |
| Q3 2025 | $2.65 | +75% |
| Q2 2025 | $2.09 | +62% |
| Q1 2025 | $1.72 | +64% |
| Q4 2024 | $1.28 | +7.6% |
VRT's earnings per share have climbed steadily: $5.35 over the past year, up 102% from the year before, and higher year over year every quarter since late 2021.
MYRG Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.3B | +32% |
| Q2 2026 | $1.1B | +20% |
| Q1 2026 | $1B | +20% |
| Q4 2025 | $973.5M | +17% |
| Q3 2025 | $950.4M | +7% |
| Q2 2025 | $900.3M | +8.6% |
| Q1 2025 | $833.6M | +2.2% |
| Q4 2024 | $829.8M | -17% |
MYRG's revenue has grown year over year for seven quarters in a row: $1.3B last quarter, up 32% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 6.8% | +1.9 points |
| Q2 2026 | 6.3% | +1.9 points |
| Q1 2026 | 6.5% | +2.4 points |
| Q4 2025 | 4.8% | +1.2 points |
| Q3 2025 | 4.9% | +2.6 points |
| Q2 2025 | 4.4% | +6.9 points |
| Q1 2025 | 4.1% | +1.1 points |
| Q4 2024 | 3.6% | -0.1 points |
MYRG's operating margin was 6.8% last quarter, up 1.9 points from the same quarter a year ago, near the top of its range since 2019.
VRT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $4.3B | +61% |
| Q2 2026 | $3.3B | +24% |
| Q1 2026 | $2.6B | +30% |
| Q4 2025 | $2.9B | +23% |
| Q3 2025 | $2.7B | +29% |
| Q2 2025 | $2.6B | +35% |
| Q1 2025 | $2B | +24% |
| Q4 2024 | $2.3B | +26% |
VRT has the edge over MYRG on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 23% | +3.5 points |
| Q2 2026 | 19% | +2.7 points |
| Q1 2026 | 17% | +2.3 points |
| Q4 2025 | 20% | +0.7 points |
| Q3 2025 | 19% | +1.4 points |
| Q2 2025 | 17% | -0.4 points |
| Q1 2025 | 14% | +1.9 points |
| Q4 2024 | 19% | +4.2 points |
VRT has the edge over MYRG on profitability, with a higher operating margin.
MYRG Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $9.2M | -86% |
| Q2 2026 | -$25.6M | -320% |
| Q1 2026 | $68.6M | -2.3% |
| Q4 2025 | $84.9M | +863% |
| Q3 2025 | $65.4M | +264% |
| Q2 2025 | $11.6M | +365% |
| Q1 2025 | $70.2M | +$88.3M |
| Q4 2024 | $8.8M | -59% |
MYRG generated $137M in free cash flow over the past year, down 12% from the year before.
VRT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $654.9M | +41% |
| Q2 2026 | $926.5M | +233% |
| Q1 2026 | $654.2M | +145% |
| Q4 2025 | $885.6M | +143% |
| Q3 2025 | $463.5M | +36% |
| Q2 2025 | $277.9M | -19% |
| Q1 2025 | $266.8M | +162% |
| Q4 2024 | $364.5M | +18% |
VRT has the edge over MYRG on cash flow, with more consistent year-over-year improvement.
MYRG Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -10K shares |
| 1 year | +0.6% | +90K shares |
| 3 years | -6.6% | -1.1M shares |
| 5 years | -8.4% | -1.4M shares |
| Available history | -5.9% | -978K shares |
MYRG has 16M diluted shares, up 0.6% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.3M |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | $75M |
| Q4 2024 | — |
MYRG has spent almost nothing on buybacks in the past year.
VRT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -64.9K shares |
| 1 year | +0.4% | +1.8M shares |
| 3 years | +1.1% | +4.4M shares |
| 5 years | +10% | +36M shares |
| Available history | +63% | +152M shares |
VRT has the edge over MYRG on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | $599.9M |
MYRG Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.6x | Very low |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.6x | Net Cash |
| Q4 2025 | -0.4x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | 0.3x | Very low |
| Q1 2025 | 0.6x | Very low |
| Q4 2024 | 0.6x | Very low |
MYRG's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
VRT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | 0.1x | Very low |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.7x | Very low |
| Q1 2025 | 0.8x | Very low |
| Q4 2024 | 1.0x | Healthy |
VRT has the edge over MYRG on leverage, with a lower net debt burden relative to earnings.
MYRG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 42.4 | Neutral |
| Stochastic | 27.3 | Neutral |
MYRG's weekly RSI is 42 (neutral) and its Stochastic is 27 (neutral).
VRT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.0 | Neutral |
| Stochastic | 26.4 | Neutral |
VRT's weekly RSI is 43 (neutral) and its Stochastic is 26 (neutral).
MYRG PE vs Industrials Sector
| Metric | MYRG | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 24x | 6% below |
| PE % | 44 | 58 | 14 pts below |
MYRG has the edge over VRT on valuation relative to its sector.
VRT PE vs Industrials Sector
| Metric | VRT | Sector median | Relative |
|---|---|---|---|
| PE | 39x | 24x | 63% above |
| PE % | 3 | 58 | 55 pts below |
VRT is trading at 39x earnings, a 63% premium to the Industrials sector's median of 24x.
MYRG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $283.5 | 1.8% below |
| 20 week MA | $317.9 | 12% below |
| 50 week MA | $319.0 | 13% below |
| 100 week MA | $242.7 | 15% above |
| 200 week MA | $188.7 | 48% above |
MYRG has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 48% above its 200-week average.
VRT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $221.8 | 5.5% below |
| 20 week MA | $254.4 | 18% below |
| 50 week MA | $253.9 | 17% below |
| 100 week MA | $189.1 | 11% above |
| 200 week MA | $123.5 | 70% above |
VRT has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 70% above its 200-week average.
MYRG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $32.1 | $60.4 | +88% |
| 2021 | $60.4 | $106.9 | +77% |
| 2022 | $106.9 | $90.3 | -16% |
| 2023 | $90.3 | $144.6 | +60% |
| 2024 | $144.6 | $150.1 | +3.8% |
| 2025 | $150.1 | $225.1 | +50% |
| 2026 YTD | $225.1 | $278.4 | +24% |
MYRG has finished higher in five of the last six years, three of them by more than 50%. It's up 24% so far in 2026.
VRT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $10.9 | $18.9 | +73% |
| 2021 | $18.9 | $24.9 | +31% |
| 2022 | $24.9 | $12.8 | -48% |
| 2023 | $12.8 | $48.0 | +275% |
| 2024 | $48.0 | $115.1 | +140% |
| 2025 | $115.1 | $167.6 | +46% |
| 2026 YTD | $167.6 | $209.6 | +25% |
VRT has the edge over MYRG on returns for 2026, with the stronger performance.